Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCHW) Other Working Capital Changes (2022 - 2025)

Historic Other Working Capital Changes for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to $118000.0.

  • Envoy Medical's Other Working Capital Changes rose 22901.16% to $118000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $480000.0, marking a year-over-year increase of 123835.22%. This contributed to the annual value of -$145000.0 for FY2024, which is 11699.88% down from last year.
  • According to the latest figures from Q3 2025, Envoy Medical's Other Working Capital Changes is $118000.0, which was up 22901.16% from -$119000.0 recorded in Q2 2025.
  • Envoy Medical's 5-year Other Working Capital Changes high stood at $703000.0 for Q3 2023, and its period low was -$459000.0 during Q4 2022.
  • Over the past 4 years, Envoy Medical's median Other Working Capital Changes value was $35865.0 (recorded in 2024), while the average stood at $62324.3.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first soared by 539605.19% in 2023, then tumbled by 49666.67% in 2025.
  • Over the past 4 years, Envoy Medical's Other Working Capital Changes (Quarter) stood at -$459000.0 in 2022, then skyrocketed by 96.73% to -$15000.0 in 2023, then surged by 2806.67% to $406000.0 in 2024, then plummeted by 70.94% to $118000.0 in 2025.
  • Its Other Working Capital Changes stands at $118000.0 for Q3 2025, versus -$119000.0 for Q2 2025 and $75000.0 for Q1 2025.